ANSHUL MAHESHWARI
Anshul Maheshwari is a specialist in the healthcare and life sciences industries with experience spanning pre-clinical start-ups to top 10 global life sciences companies. With over 15 years of experience, he has a deep understanding of the evolving healthcare landscape and the life sciences value chain from research and development through to commercialization.
His background comprises of working on biomedical start-ups, consulting for medical device and pharma companies and leading the innovation strategy for medical aesthetics. His wide functional expertise includes strategic planning, business development, commercial operations, business transformation and product commercialization.
Anshul co-founded the pioneering Balanced Skin Dermatology and Aesthetics medical office in Newport Beach and co-leads an advisory and collaborative practice in health, beauty and wellness with his wife and partner, Dr. Tia Paul. He is passionate about empowering medical professionals to pursue entrepreneurship and has helped several physicians in starting their own enterprise.
EDUCATION
2008 – 2009
Cornell University | Ithaca, NY
Master's in Biomedical Engineering (Bio-instrumentation & Innovation Management)
2004 – 2008
Illinois Institute of Technology | Chicago, IL
Bachelor's in Biomedical Engineering | Ed Kaplan Entrepreneur Fellowship
EXPERIENCE
Balanced Skin Dermatology and Aesthetics
2024 - 2025
Managing Partner
Responsible for administrative and managerial activities including industry joint-ventures, marketing and branding, technology acquisition and people management, along with growth and scaling of the medical practice.
Allergan Aesthetics, Abbvie
2022 - 2025
Director of Innovation Strategy
Defined and led programs in medical aesthetics to capture value from emerging market dynamics and upcoming technologies such as GLP-1 medical weight loss, AI visualization, new business models and energy-based modalities.
Gilead Sciences
2021 - 2022
Chief Commercial Officer, Chief of Staff Team
Led organization-wide operational efficiencies projects including promotional review process improvement, supplier selection and engagement, customer engagement and talent development projects as part of the CCO's efficiency objectives
Ernst & Young
2017 – 2021
Director, Life Sciences Strategy
Managed pipeline of life sciences projects with global pharma and medical device companies which include opportunity assessment, revenue forecasting, pricing strategy, go-to-market strategy, strategic planning, project portfolio rationalization, and digital strategy
PA Consulting Group
2011 – 2017
Analyst to Principal Consultant, Life Sciences Strategy
Supported and led projects with global life sciences companies which include M&A opportunity assessment, customer engagement strategy, commercial operations reform and digital transformation while generating research and insights on technology in healthcare
Harvard-MIT Center for Engineering in Medicine
2009 – 2011
Applications Engineer
Designed and led the scale-up and testing of a range of 'lab on a chip' technologies that separate and capture specific cell sub-populations from blood with applications in oncology, infectious diseases and inflammation
PRO BONO ACTIVITIES
- Development and launch support for medical practices (2022-2025)
- Market assessment and business model development of at-home veterinary care (2018)
- New market entry of existing motorcycle parts business in emerging markets (2016)
- Development of a global health guidelines database for HIV-related skin disorders (2014)
- New business models for in vitro diagnostics - NanoBioSym (2012)